Resultado da Busca
Há 2 dias · This acquisition allows GSK to integrate Elsie’s oligonucleotide discovery, synthesis, and delivery technologies to enhance GSK’s platform R&D capabilities. This follows a successful research collaboration with Elsie, announced in July 2023, in which GSK was able to explore and validate the technology.
Há 5 dias · Publicidade. (Reuters) – As ações da GSK caíram mais de 9% nesta segunda-feira, depois que um juiz dos Estados Unidos permitiu o avanço de mais de 70.000 ações judiciais que alegam que o ...
Há 4 dias · Shares of GSK dropped more than 9% on Monday, after a Delaware judge allowed more than 70,000 lawsuits alleging its discontinued heartburn drug Zantac caused cancer, to go forward, in a blow for ...
Há 5 dias · Dostarlimab is not approved anywhere in the world for the frontline treatment of locally advanced dMMR rectal cancer. GSK is advancing studies evaluating dostarlimab in patients with advanced/metastatic stages of dMMR/MSI-H colorectal cancer through its AZUR clinical trial programme.
Há 5 dias · GSK and the other drugmakers that sold Zantac dispute these claims. The London-listed group said it planned to appeal against the Delaware ruling. Shares in GSK were down 9.5 per cent on Monday ...
Há 4 dias · GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer,...
Há 3 dias · Giving researchers access to rich biological data at scale is crucial to accelerating drug discovery. Here, Chris Austin, Senior Vice President of Research Technologies at GSK, explains why – and why a diverse skillset is needed to do this well and responsibly.
